Sponsors

Dear sponsor,

After the huge success of our CTAD09 last October in Las Vegas we would like to let you know that the 3rd edition of our Clinical Trials for Alzheimer’s Disease CtaD10 will be held in Toulouse (France) November 3-5, 2010.

The aims of the meeting are to bring together today’s worldwide leaders in clinical trials on Alzheimer’s Disease to discuss new results, drugs in development, and future methodological issues .

Again this year we are happy to extend a partnership opportunity to a limited number of leading organizations in this specific field. These past two years the following Pharmaceutical Labs were our privileged partners : EISAI, IPSEN, JANSSEN-CILAG, LILLY, LUNDBECK, NOVARTIS, SANOFI AVENTIS, WYETH, ELAN, PFIZER. They benefited from a great networking opportunity throughout the conference as well as a high-level visibility of their company’s logo. This venue was a fabulous opportunity for our major sponsors to reach over 300 high-level international decision-makers in the field of research on Alzheimer’s Disease.

In Toulouse in 2010 we will again get together to create a forum for discussion among key opinion leaders in therapy development for Alzheimer’s disease. The topics of discussion will include preliminary or new results concerning drug discovery, clinical trials of new therapies in development, methodological issues relating to disease modifying treatments, outcome measurements, biomarkers validation and health economics.

Some of our partner have already committed to CTAD 2010!

Sign-up quickly as we will only accept a limited number major sponsors!


If you want more details regarding sponsoring opportunities as well as more information on the conference itself, please contact : ctad@ant-congres.com